First Time Loading...

Clearside Biomedical Inc
NASDAQ:CLSD

Watchlist Manager
Clearside Biomedical Inc Logo
Clearside Biomedical Inc
NASDAQ:CLSD
Watchlist
Price: 1.31 USD -0.76% Market Closed
Updated: May 4, 2024
Section:
 

Wall Street
Price Targets

CLSD Price Targets Summary
Clearside Biomedical Inc

Wall Street analysts forecast CLSD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CLSD is 5.61 USD with a low forecast of 4.04 USD and a high forecast of 8.4 USD.

CLSD Lowest Forecast
Wall Street Target
4.04 USD
208% Upside
CLSD Average Forecast
Wall Street Target
5.61 USD
328% Upside
CLSD Highest Forecast
Wall Street Target
8.4 USD
541% Upside
Lowest
Price Target
4.04 USD
208% Upside
Average
Price Target
5.61 USD
328% Upside
Highest
Price Target
8.4 USD
541% Upside
Clearside Biomedical Inc Competitors:
Price Targets
K
KOTRA
Kotra Industries Bhd
18% Upside
L
503
Lansen Pharmaceutical Holdings Ltd
78% Downside
FULC
Fulcrum Therapeutics Inc
74% Upside
Z
603079
Zhejiang Shengda Bio-Pharm Co Ltd
18% Upside
K
KOTRA
Kotra Industries Bhd
18% Upside
L
503
Lansen Pharmaceutical Holdings Ltd
78% Downside
FULC
Fulcrum Therapeutics Inc
74% Upside
Z
603079
Zhejiang Shengda Bio-Pharm Co Ltd
18% Upside
G
GLS
Glenmark Life Sciences Ltd
11% Upside
ANCR
Animalcare Group PLC
27% Upside
LLY
Eli Lilly and Co
15% Upside
326030
SK Biopharmaceuticals Co Ltd
29% Upside

Revenue
Forecast

Revenue Estimate
Clearside Biomedical Inc

The compound annual growth rate of Clearside Biomedical Inc's revenue for the next 3 years is 40%.

N/A
Past Growth
40%
Estimated Growth
Estimates Accuracy
17%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Clearside Biomedical Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Clearside Biomedical Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-52%
Average Miss
What are analyst estimates?

See Also

Summary
CLSD intrinsic value, competitors valuation, and company profile.
DCF Valuation
CLSD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CLSD stock valuation using valuation multiples.
Wall Street Estimates
CLSD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CLSD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CLSD's stock price target?
Price Target
5.61 USD

According to Wall Street analysts, the average 1-year price target for CLSD is 5.61 USD with a low forecast of 4.04 USD and a high forecast of 8.4 USD.

What is Clearside Biomedical Inc's Revenue forecast?
Projected CAGR
40%

The compound annual growth rate of Clearside Biomedical Inc's revenue for the next 3 years is 40%.

ALPHA SPREAD
Join more than 134,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.